CNTX Context Therapeutics Inc
Company Analysis
Latest News
🔴 Context Therapeutics drops in after-hours trading ahead of Q2 earnings
Context Therapeutics is trading at $0.56 (down approx. 18.8% from its daily close of $0.69) in after-hours as investors react to upcoming Q2 2026 earnings. * ...
🔴 Context Therapeutics is trading 6.3% down today as investors take profits ahead of Q2 earnings and clinical updates
Context Therapeutics is trading at $0.65 (6.3% down) in after-hours trading following a strong regular session driven by anticipation of its Q2 2026 earnings...
🟢 Context Therapeutics is trading 6.1% up today ahead of Q2 earnings and clinical updates
Context Therapeutics is trading at $0.66 (+6.11%) as investors position ahead of the company’s Q2 2026 earnings report and monitor clinical progress for...
🟢 Context Therapeutics is trading 5.4% up today on Q2 earnings optimism and clinical progress
Context Therapeutics is trading 5.4% up at $0.64 as investors position ahead of the company’s Q2 2026 earnings report and monitor clinical progress for...
Context Therapeutics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
Context Therapeutics is expected to report a consensus EPS of -$0.10 on zero revenue for the second quarter, with the current stock price of $0.62 reflecting...
🟢 Context Therapeutics is trading 5% up today amid broader market strength
Context Therapeutics is trading 5% up at $0.63, rebounding modestly from recent weakness as the broader market shows a risk-on tone. • The move appears...
🔴 Context Therapeutics is trading 5.1% down today amid broader market weakness and thin liquidity
Context Therapeutics is trading at $0.59 (5.1% down) in after-hours trading as broader market weakness and thin liquidity weigh on the small-cap biotech. •...
🔴 Context Therapeutics is trading 5% down today on profit-taking after recent strength
Context Therapeutics is trading 5% down at $0.59 today, giving back a portion of last week’s biotech-driven gains. • No new company-specific filings, clinical...
🟢 Context Therapeutics rises 5.2% — Biotech Sector Rallies on Blockbuster M&A Deal and Positive Trial Data
With Biotech (XBI) up 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 Context Therapeutics is trading 6% down today with no clear catalyst identified
Context Therapeutics is trading 6% down at $0.58 in after-hours trading, retreating from its recent $0.61 regular-session close. • The move comes without any...
🟢 Context Therapeutics is trading 5.5% up today, extending a multi-day rebound
Context Therapeutics is trading 5.5% up today at $0.69, extending a multi-day rebound from last week’s lows. • The move appears to be follow-through price...
🟢 Context Therapeutics is trading 12.7% up
Context Therapeutics is trading at $0.67, up 12.7% from a comparison close of $0.59 during regular trading. This is a price-action follow-up, so a separate...
🟢 Context Therapeutics is trading 7.7% up today in a technical rebound after recent volatility
Context Therapeutics is trading at $0.64, up 7.7%, in a technical rebound following sharp swings and significant selling pressure earlier this week. • The...
🟢 Context Therapeutics is trading 6.3% up today in a technical rebound after recent volatility
Context Therapeutics is trading 6.3% up at $0.63 in a technical rebound following several days of sharp price swings. • The stock experienced a 14.9% drop on...
🔴 Context Therapeutics is trading 5.3% down today on follow-through selling after recent volatility
Context Therapeutics is trading at $0.56 (5.3% down), extending its downward trend after a 14.9% drop on July 8 and a week marked by significant double-digit...
🟢 Context Therapeutics is trading 5.8% up today in a technical bounce after recent losses
Context Therapeutics is trading at $0.63 (5.8% up) in pre-market, staging a modest recovery following a sharp 14.9% sell-off on July 8. * The current move...
🔴 CNTX makes sharp 11.0% drop
CNTX is trading at $0.62, down 11.0% versus the comparison close of $0.70 during regular trading. This is a price-movement alert; no separate company-specific...
CNTX Pulls Back After Index-Fueled Rally — Can a Sub-Dollar Biotech Sustain Momentum Without Clinical Catalysts?
Shares of Context Therapeutics slid 8.6% to $0.64 on July 8, erasing gains from a sharp rally that lifted the stock roughly 16% over the prior week. The...
🔴 CNTX is trading 8.6% down today after recent analyst-driven rally and Russell index inclusion
CNTX is trading at $0.64 (8.6% down) today as the stock pulls back from a sharp rally fueled by analyst optimism and index inclusion news. • The recent upward...
🟢 CNTX is trading 5% up today on bullish analyst ratings and Russell Index inclusion
• CNTX is trading 5% up today at $0.67 on bullish analyst sentiment and aggressive price targets, alongside its recent inclusion in the Russell 2000 and...